| Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cells MD Zhou, S Hao, AJ Williams, RA Harouaka, B Schrand, S Rawal, Z Ao, ... Scientific reports 4 (1), 7392, 2014 | 125 | 2014 |
| iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease B Martin, R Brenneman, KG Becker, M Gucek, RN Cole, S Maudsley PloS one 3 (7), e2750, 2008 | 125 | 2008 |
| Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders L Wang, B Martin, R Brenneman, LM Luttrell, S Maudsley Journal of Pharmacology and Experimental Therapeutics 331 (2), 340-348, 2009 | 122 | 2009 |
| Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender X Xu, M Zhan, W Duan, V Prabhu, R Brenneman, W Wood, J Firman, H Li, ... Genome biology 8, 1-17, 2007 | 113 | 2007 |
| Class II G protein-coupled receptors and their ligands in neuronal function and protection B Martin, RL De Maturana, R Brenneman, T Walent, MP Mattson, ... Neuromolecular medicine 7, 3-36, 2005 | 105 | 2005 |
| Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy B Schrand, A Berezhnoy, R Brenneman, A Williams, A Levay, LY Kong, ... Cancer immunology research 2 (9), 867-877, 2014 | 101 | 2014 |
| Complex and multidimensional lipid raft alterations in a murine model of Alzheimer′ s disease W Chadwick, R Brenneman, B Martin, S Maudsley International Journal of Alzheimer’s Disease 2010 (1), 604792, 2010 | 84 | 2010 |
| Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment A Levay, R Brenneman, J Hoinka, D Sant, M Cardone, G Trinchieri, ... Nucleic acids research 43 (12), e82-e82, 2015 | 77 | 2015 |
| Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males B Martin, M Pearson, R Brenneman, E Golden, A Keselman, T Iyun, ... PloS one 3 (6), e2398, 2008 | 58 | 2008 |
| Targeting cisplatin-resistant human tumor cells with metabolic inhibitors EJ Sullivan, M Kurtoglu, R Brenneman, H Liu, TJ Lampidis Cancer chemotherapy and pharmacology 73, 417-427, 2014 | 57 | 2014 |
| Growth factor signals in neural cells: coherent patterns of interaction control multiple levels of molecular and phenotypic responses B Martin, R Brenneman, E Golden, T Walent, KG Becker, VV Prabhu, ... Journal of Biological Chemistry 284 (4), 2493-2511, 2009 | 42 | 2009 |
| Gonadal transcriptome alterations in response to dietary energy intake: sensing the reproductive environment B Martin, M Pearson, R Brenneman, E Golden, W Wood III, V Prabhu, ... PLoS One 4 (1), e4146, 2009 | 41 | 2009 |
| GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats W Chadwick, B Martin, MC Chapter, SS Park, L Wang, CM Daimon, ... PLoS One 7 (5), e36975, 2012 | 40 | 2012 |
| Radiation-induced enhancement of antitumor T-cell immunity by VEGF-targeted 4-1BB costimulation B Schrand, B Verma, A Levay, S Patel, I Castro, AP Benaduce, ... Cancer research 77 (6), 1310-1321, 2017 | 37 | 2017 |
| Thermal stability of siRNA modulates aptamer-conjugated siRNA inhibition A Berezhnoy, R Brenneman, M Bajgelman, D Seales, E Gilboa Molecular Therapy-Nucleic Acids 1, 2012 | 37 | 2012 |
| Abscopal effect following proton beam radiotherapy in a patient with inoperable metastatic retroperitoneal sarcoma RJ Brenneman, N Sharifai, B Fischer-Valuck, C Hassanzadeh, J Guzelian, ... Frontiers in Oncology 9, 922, 2019 | 33 | 2019 |
| Association between surgical margins larger than 1 cm and overall survival in patients with Merkel cell carcinoma N Andruska, BW Fischer-Valuck, L Mahapatra, RJ Brenneman, HA Gay, ... JAMA dermatology 157 (5), 540-548, 2021 | 28 | 2021 |
| Reducing toxicity of 4–1BB costimulation: targeting 4–1BB ligands to the tumor stroma with bi-specific aptamer conjugates B Schrand, A Berezhnoy, R Brenneman, A Williams, A Levay, E Gilboa Oncoimmunology 4 (3), e970918, 2015 | 27 | 2015 |
| A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the … BW Fischer-Valuck, JM Michalski, JA Contreras, R Brenneman, ... Clinical and translational radiation oncology 15, 38-41, 2019 | 20 | 2019 |
| Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity B Schrand, E Clark, A Levay, AR Capote, O Martinez, R Brenneman, ... Nature communications 9 (1), 3348, 2018 | 18 | 2018 |
Stuart MaudsleyOdysseus Professor of Receptor Pharmacology and Chief - Receptor Biology Lab在 uantwerpen.be 的电子邮件经过验证
